Remove 2022 Remove BioTech Remove Life Science Remove Telecare
article thumbnail

AstraZeneca launches Evinova, a health-tech business to accelerate innovation across the life sciences sector, the delivery of clinical trials and better health outcomes

Digital Health Global

With long-term backing from AstraZeneca and strategic collaborations with Parexel and Fortrea, Evinova offers globally-scaled digital products and services to the life sciences and healthcare sector. CAGR 2022-2032) market. 2 Digital health is a large (+$900bn by 2032) and growing (13.6% Available at: [link].